Novel technologies and approaches aid percutaneous management of valvular and other structural heart diseases

Our department utilizes the most advanced, novel technologies and approaches available to manage complex patients and guide structural interventions.

In 2021, we performed over 300 percutaneous valve repair procedures. We are among the first hospitals in the country to adopt novel electrosurgical technologies and approaches for managing complex patients, such as:

  • Basilica: coronary leaflet laceration to prevent coronary obstructio
  • Transcaval TAVR to obtain percutaneous femoral access in patients with advanced peripheral arterial disease
  • Tip-to-base LAMPOON and antegrade LAMPOON to perform anterior mitral valve leaflet laceration to prevent LV outflow tract obstruction

We utilize the most advanced imaging technologies to plan and guide structural interventions, such as 4D intracardiac echocardiography (ICE). Our team participates in and leads the most important clinical trials in structural disease, including:

  • Intrepid TTVR EFS: Intrepid Valve for Tricuspid Regurgitation (National PI)
  • TRILUMINATE: Randomized Trial of TriClip for Tricuspid Regurgitation
  • CLASP 2D/2F: Randomized study of PACAL vs. MitraClip for Severe MR
  • TRISCEND PIVOTAL: Randomized study of Evoque valve for Tricuspid Regurgitation
  • ACURATE IDE: Randomized Trial of Acurate Valve vs. Commercial Valves for Aortic Stenosis

Patient referrals

At Montefiore Einstein Center for Heart and Vascular Care, we know providing patients with the best possible care includes teamwork and trust. We work closely with our valued referring physicians to ensure open communication and reliable expertise.